VANI Stock Summary and Trading Ideas (Vivani Medical | NASDAQ:VANI)

Vivani Medical Inc is a clinical-stage biopharmaceutical company whose primary focus is the development of miniature subdermal drug implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases with once or twice-yearly administration. Its flagship drug implant candidates are designed to improve medication adherence and provide smooth, consistent therapeutic levels of GLP-1, the same class of active pharmaceutical ingredients used in Ozempic, Trulicity, and Wegovy.

Vivani Medical trades on the NASDAQ stock market under the symbol VANI.

As of February 24, 2026, VANI stock price climbed to $1.27 with 23,922 million shares trading.

VANI has a beta of 1.01, meaning it tends to be more sensitive to market movements. VANI has a correlation of 0.09 to the broad based SPY ETF.

VANI has a market cap of $103.13 million. This is considered a Micro Cap stock.

In the last 3 years, VANI traded as high as $7.80 and as low as $.75.

The top ETF exchange traded funds that VANI belongs to (by Net Assets): VTI, VXF, IWC.

VANI has underperformed the market in the last year with a price return of +10.4% while the SPY ETF gained +15.7%. VANI has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -3.8% and -1.6%, respectively, while the SPY returned +4.5% and -1.0%, respectively.

VANI support price is $1.19 and resistance is $1.31 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that VANI shares will trade within this expected range on the day.